2007
DOI: 10.1016/j.bios.2006.06.005
|View full text |Cite
|
Sign up to set email alerts
|

Bead-based microfluidic immunoassays: The next generation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
101
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 249 publications
(101 citation statements)
references
References 55 publications
0
101
0
Order By: Relevance
“…They have, however, not been exploited at all in the microfluidics context. Recent modelling (Derksen, 2008(Derksen, , 2009) and experimental work (Doroodchi et al, 2012;Potic et al, 2005;Zivkovic et al, 2013a;Zivkovic et al, 2013b) has demonstrated that microfluidic fluidized beds (termed henceforth 'microfluidized beds') are feasible, offering the potential to not only overcome diffusion-limited heat and mass transport in simple micron-sized channels, but also provide higher sensitivity and multi-modal detection in the diagnostic context by virtue of the large surface area per unit volume that comes from use of micro-particles (Derveaux et al, 2008;Lim and Zhang, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…They have, however, not been exploited at all in the microfluidics context. Recent modelling (Derksen, 2008(Derksen, , 2009) and experimental work (Doroodchi et al, 2012;Potic et al, 2005;Zivkovic et al, 2013a;Zivkovic et al, 2013b) has demonstrated that microfluidic fluidized beds (termed henceforth 'microfluidized beds') are feasible, offering the potential to not only overcome diffusion-limited heat and mass transport in simple micron-sized channels, but also provide higher sensitivity and multi-modal detection in the diagnostic context by virtue of the large surface area per unit volume that comes from use of micro-particles (Derveaux et al, 2008;Lim and Zhang, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…56 The aggregation of Ab-MPs can form conveniently and rapidly; the total testing time (needed for both immunoaggregation and the detection) is approximately 1 h, which is faster than the conventional ELISA (requiring several hours to 2 days). 49 The sensor chip, made of PDMS and glass, is cost effective and portable, making it suitable for rapid, onsite, quantitative detection of multiple biomarkers. Recently, Hauer et al reported a two-stage device consisting of a tunable RPS to measure the size and concentration of microparticles, and fluorescence spectroscopy to detect the fluorescent labels simultaneously.…”
Section: Resultsmentioning
confidence: 99%
“…47,48 Recently, microparticle-enhanced immunoassays have attracted many attentions because surface functionalization of microparticles (MPs) is flexible and fast. 49,50 Among these microparticle-based immunoassays, immunoaggregation assays based on the aggregation of antibody functionalized MPs (Ab-MPs) triggered by target biomarkers enable direct measurement of a target biomarker concentration with only one step 51 without fluorescent, enzymatic, or radioactive labeling. However, traditional immunoaggregation detection method such as turbidimetry, nephelometry, and optical detection can only detect biomarkers with a relatively high concentration.…”
Section: Introductionmentioning
confidence: 99%
“…Particularly common is plate-based ELISA, in which antibodies are coated onto wells of a plate and incubated with clinical liquid samples. As a variation on plate-based ELISA, microbeads offer improved assay sensitivity and simplification of microfluidic device design [97,98]. In a typical microbead immunoassay, primary antibodies are bound to the beads, providing a larger surface area-to-volume ratio for antigen capture as compared to the plate format of ELISA; this increased surface area-to-volume ratio improves sample mixing efficiency and antigen capture.…”
Section: Antibody-bonded Substratesmentioning
confidence: 99%